RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+4.64%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$487M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,480
New
178
Increased
2,059
Reduced
1,848
Closed
61
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$99.6M |
| 2 |
GE Vernova
GEV
|
+$81.6M |
| 3 |
CrowdStrike
CRWD
|
+$52.8M |
| 4 |
CRH
CRH
|
+$45.6M |
| 5 |
Dell
DELL
|
+$36.8M |
Top Sells
| 1 |
iShares Russell 1000 ETF
IWB
|
+$186M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$58.8M |
| 4 |
UnitedHealth
UNH
|
+$48.4M |
| 5 |
NVIDIA
NVDA
|
+$46.8M |
Sector Composition
| 1 | Technology | 31% |
| 2 | Financials | 12.54% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Pearson
PSO
$9.18B
| $144K | ﹤0.01% |
11,518
+1,281
| +13% | +$16K |
|
3152
Candel Therapeutics
CADL
$274M
| $143K | ﹤0.01% |
+22,985
| New | +$143K |
|
3153
RAPT Therapeutics
RAPT
$253M
| $142K | ﹤0.01% |
5,814
+373
| +7% | +$9.1K |
|
3154
Nerdy
NRDY
$158M
| $142K | ﹤0.01% |
84,739
+8,834
| +12% | +$14.8K |
|
3155
Townsquare Media
TSQ
$117M
| $139K | ﹤0.01% |
12,660
+2,481
| +24% | +$27.2K |
|
3156
Lifecore Biomedical
LFCR
$264M
| $138K | ﹤0.01% |
26,899
+25,378
| +1,669% | +$130K |
|
3157
iShares Russell 2000 Value ETF
IWN
$12B
| $138K | ﹤0.01% |
905
-4,129
| -82% | -$629K |
|
|
KPN
3158
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
| $138K | ﹤0.01% |
36,402
+9,491
| +35% | +$35.9K |
|
3159
Q32 Bio
QTTB
$22.4M
| $137K | ﹤0.01% |
7,658
+7,593
| +11,682% | +$136K |
|
3160
LINKBANCORP
LNKB
$272M
| $137K | ﹤0.01% |
+22,401
| New | +$137K |
|
|
RGLS
3161
DELISTED
Regulus Therapeutics
RGLS
| $136K | ﹤0.01% |
+76,472
| New | +$136K |
|
3162
InnovAge Holding
INNV
$558M
| $136K | ﹤0.01% |
27,503
+1,793
| +7% | +$8.89K |
|
3163
Franco-Nevada
FNV
$38.7B
| $136K | ﹤0.01% |
1,150
-237
| -17% | -$28.1K |
|
3164
Harvard Bioscience
HBIO
$19.9M
| $136K | ﹤0.01% |
47,753
+9,512
| +25% | +$27.1K |
|
3165
Bank7 Corp
BSVN
$463M
| $136K | ﹤0.01% |
4,336
-249
| -5% | -$7.79K |
|
3166
Waldencast
WALD
$213M
| $134K | ﹤0.01% |
37,408
-964
| -3% | -$3.46K |
|
3167
Eastern Company
EML
$147M
| $134K | ﹤0.01% |
+5,261
| New | +$134K |
|
3168
Century Therapeutics
IPSC
$43.4M
| $134K | ﹤0.01% |
52,466
+18,828
| +56% | +$48K |
|
3169
Perma-Fix Environmental Services
PESI
$186M
| $134K | ﹤0.01% |
+13,200
| New | +$134K |
|
3170
Geospace Technologies
GEOS
$218M
| $133K | ﹤0.01% |
14,824
+14,224
| +2,371% | +$128K |
|
3171
Kodiak Sciences
KOD
$527M
| $133K | ﹤0.01% |
56,511
+586
| +1% | +$1.38K |
|
3172
CompoSecure
CMPO
$1.99B
| $133K | ﹤0.01% |
23,503
+3,464
| +17% | +$19.6K |
|
3173
iShares MSCI Netherlands ETF
EWN
$258M
| $133K | ﹤0.01% |
2,638
| – | – |
|
3174
Traeger
COOK
$177M
| $132K | ﹤0.01% |
55,148
+767
| +1% | +$1.84K |
|
3175
Lineage Cell Therapeutics
LCTX
$290M
| $132K | ﹤0.01% |
132,491
+17,411
| +15% | +$17.4K |
|